Jinyu Bio-Technology News and Activities

Jinyu Bio-Technology is a company listed under the stock ticker 600201 (CN).

View the org chart displaying its 9 main executives

Most searched biographies at Jinyu Bio-Technology

• Jing Zhang, Chief Executive Officer and Vice Chairman of the Board
• Zhenping Wu, Independent Director
• Riming Gao, Director

Create your alert
to follow the executive moves at Jinyu Bio-Technology.

Jinyu Bio-Technology has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Jinyu Bio-Technology

Social media about Jinyu Bio-Technology

• Jinyu Bio-Technology on Wikipedia, Google News & Yahoo Finance
• Jinyu Bio-Technology on LinkedIn, X (Twitter) & YouTube